Public Sector Pension Investment Board (PSP Investments)’s Catalyst Pharmaceutical CPRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$13M Buy
526,349
+33,410
+7% +$796K 0.04% 423
2025
Q4
$11.5M Sell
492,939
-23,806
-5% -$530K 0.04% 410
2025
Q3
$10.2M Buy
516,745
+50,343
+11% +$1.04M 0.04% 441
2025
Q2
$10.1M Buy
466,402
+55,640
+14% +$1.31M 0.04% 373
2025
Q1
$9.96M Buy
410,762
+131,283
+47% +$2.96M 0.04% 374
2024
Q4
$5.83M Buy
279,479
+42,759
+18% +$919K 0.02% 565
2024
Q3
$4.71M Sell
236,720
-10,200
-4% -$189K 0.03% 507
2024
Q2
$3.82M Buy
246,920
+17,056
+7% +$266K 0.02% 546
2024
Q1
$3.66M Buy
229,864
+21,900
+11% +$330K 0.03% 508
2023
Q4
$3.5M Buy
207,964
+84,133
+68% +$1.15M 0.03% 515
2023
Q3
$1.45M Sell
123,831
-49,231
-28% -$659K 0.01% 943
2023
Q2
$2.33M Buy
173,062
+4,668
+3% +$67.2K 0.02% 840
2023
Q1
$2.79M Sell
168,394
-5,794
-3% -$95.6K 0.02% 733
2022
Q4
$3.24M Buy
174,188
+795
+0.5% +$12.2K 0.02% 645
2022
Q3
$2.23M Buy
+173,393
New +$2.05M 0.02% 774

Other funds holding CPRX

Public Sector Pension Investment Board (PSP Investments)'s CPRX Position: Q1 2026 in Review

Public Sector Pension Investment Board (PSP Investments) increased its Catalyst Pharmaceutical (CPRX) stake by 6.8% in Q1 2026, buying an estimated $796K and bringing the position to 526,349 shares worth $13M. The position accounts for 0.04% of the portfolio, ranked #423.

Public Sector Pension Investment Board (PSP Investments) first reported a position in CPRX in Q3 2022 and has held it in 15 quarters since. 381 funds tracked by Wall St. Rank hold CPRX as of Q1 2026.

  • Public Sector Pension Investment Board (PSP Investments) held 526,349 shares of Catalyst Pharmaceutical worth $13M as of Q1 2026.
  • Public Sector Pension Investment Board (PSP Investments) bought 33,410 Catalyst Pharmaceutical shares in Q1 2026, an estimated $796K.
  • Catalyst Pharmaceutical made up 0.04% of Public Sector Pension Investment Board (PSP Investments)'s portfolio in Q1 2026, its #423 holding.
  • Public Sector Pension Investment Board (PSP Investments) first reported a position in Catalyst Pharmaceutical in Q3 2022 and has held it in 15 quarters since.
  • 381 funds tracked by Wall St. Rank held Catalyst Pharmaceutical as of Q1 2026.

Based on Public Sector Pension Investment Board (PSP Investments)'s 13F filing for Q1 2026, filed 13 May 2026.